| Dr Sean C Keller, | |
|
13100 E 136th St, Ste 1200, Fishers, IN 46037-9417 | |
| (317) 678-3100 | |
| (317) 678-3108 |
| Full Name | Dr Sean C Keller |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 25 Years |
| Location | 13100 E 136th St, Fishers, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164466421 | NPI | - | NPPES |
| 200449180 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 01053956 (Indiana) | Secondary |
| 207R00000X | Internal Medicine | 01053956 (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana University Health Care Associates Inc | 5799755864 | 882 |
News Archive
Researchers at Indiana University School of Medicine are testing use of tezampanel, a novel antagonist at glutamate receptors that could treat opioid withdrawal syndrome and other addictions and mental illnesses.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent PC Neuromodulation System and Macroplastique urethral bulking agent products are scheduled to be presented at three upcoming professional meetings.
IDEX Corporation today announced that it has entered into a definitive merger agreement to acquire Microfluidics International Corporation for $1.35 per share, net to the seller in cash, and subject to adjustment as provided in the merger agreement. The transaction is expected to close in the first quarter of 2011.
The most common medical approach to terminating early pregnancy — the drug RU-486 plus prostaglandins — remains the most effective nonsurgical abortion method, according to a new research review.
› Verified 8 days ago
| Entity Name | Indiana University Health Care Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902032832 PECOS PAC ID: 5799755864 Enrollment ID: O20040727000955 |
News Archive
Researchers at Indiana University School of Medicine are testing use of tezampanel, a novel antagonist at glutamate receptors that could treat opioid withdrawal syndrome and other addictions and mental illnesses.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent PC Neuromodulation System and Macroplastique urethral bulking agent products are scheduled to be presented at three upcoming professional meetings.
IDEX Corporation today announced that it has entered into a definitive merger agreement to acquire Microfluidics International Corporation for $1.35 per share, net to the seller in cash, and subject to adjustment as provided in the merger agreement. The transaction is expected to close in the first quarter of 2011.
The most common medical approach to terminating early pregnancy — the drug RU-486 plus prostaglandins — remains the most effective nonsurgical abortion method, according to a new research review.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sean C Keller, 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Dr Sean C Keller, 13100 E 136th St, Ste 1200, Fishers, IN 46037-9417 Ph: (317) 678-3100 |
News Archive
Researchers at Indiana University School of Medicine are testing use of tezampanel, a novel antagonist at glutamate receptors that could treat opioid withdrawal syndrome and other addictions and mental illnesses.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent PC Neuromodulation System and Macroplastique urethral bulking agent products are scheduled to be presented at three upcoming professional meetings.
IDEX Corporation today announced that it has entered into a definitive merger agreement to acquire Microfluidics International Corporation for $1.35 per share, net to the seller in cash, and subject to adjustment as provided in the merger agreement. The transaction is expected to close in the first quarter of 2011.
The most common medical approach to terminating early pregnancy — the drug RU-486 plus prostaglandins — remains the most effective nonsurgical abortion method, according to a new research review.
› Verified 8 days ago
Dr. Michele J Ostrowski, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7199 Easy St, Fishers, IN 46038 Phone: 317-415-6110 | |
Tammy N Durham-boring, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 9894 E 121st St, Fishers, IN 46037 Phone: 317-621-6060 Fax: 317-355-6965 | |
Racquel Kukita Reyes, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7199 Easy St, Fishers, IN 46038 Phone: 317-415-6110 | |
Anna Marie C Sander, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 12677 Brookhaven Dr, Fishers, IN 46037 Phone: 317-219-5188 | |
Dr. Derrick A Williams, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 13914 Southeastern Parkway, Suite 210, Fishers, IN 46037 Phone: 317-419-9900 Fax: 317-415-9910 | |
Sridevi A Vedantam, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 10318 Copper Ridge Dr, Fishers, IN 46040 Phone: 765-965-6566 | |
Dr. Peter Caccavallo, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13000 E 136th St, Suite 1100, Fishers, IN 46037 Phone: 317-678-3585 Fax: 317-863-5084 |